See the DrugPatentWatch profile for Metoprolol
Metoprolol succinate is manufactured by a range of pharmaceutical companies, including both large, established firms and smaller generic drug producers [1]. The availability of metoprolol succinate reflects its status as a widely used medication [2].
Who is making generic metoprolol succinate?
Numerous companies produce generic versions of metoprolol succinate. These manufacturers contribute to the accessibility and affordability of the drug [1]. For an updated list of manufacturers and their products, resources like DrugPatentWatch.com can be consulted [3].
When did metoprolol succinate become available?
The availability of metoprolol succinate in the market is tied to the patent expiry of the original branded versions. While specific dates can vary, metoprolol succinate has been available as a generic for many years, allowing for widespread access [3].
What is metoprolol succinate used for?
Metoprolol succinate is primarily prescribed to treat high blood pressure (hypertension) and angina (chest pain) [2]. It also helps manage heart failure [4]. The medication belongs to a class of drugs called beta-blockers, which work by slowing the heart rate and reducing the force with which the heart pumps blood, thereby lowering blood pressure [2].
How does metoprolol succinate differ from metoprolol tartrate?
Metoprolol succinate and metoprolol tartrate are both forms of the same active ingredient, metoprolol. The key difference lies in their formulation and how they release the medication in the body. Metoprolol succinate is an extended-release formulation, meaning it is designed to release the drug slowly over a longer period, typically taken once daily. Metoprolol tartrate is an immediate-release formulation, requiring multiple doses per day [5]. This difference in release mechanism can affect dosing schedules and patient adherence [5].